Biotech Daily: Adalta IPO To Raise $10m For AD-114 For Fibrosis
News & Media
AdAlta and The University of Melbourne to develop i-bodies for the treatment of various eye diseases
Lonza and AdAlta Announce a Strain Development Contract for Novel Biologic Therapeutics
AdAlta collaborates with Crossbeta to find i-body for Alzheimer’s disease
AdAlta awarded voucher to explore benefits of technologies with Ferring Research Institute